A Registry of Tuberculosis Cases in the CPCRA
Data Collection
Collected at a single point in time - Cross-sectionalBlood-Borne Infections+21
+ Urogenital Diseases
+ Genital Diseases
Summary
Study start date: August 1, 1992
Actual date on which the first participant was enrolled.Geographic areas and demographic subgroups affected by the TB epidemic appear to be congruent and associated with the concurrent HIV epidemic. The total number of CPCRA patients who will develop, or who have experienced, confirmed TB is unknown. It is critical to determine the depth and breadth of the current problem of drug-resistant TB. For both retrospective and prospective components of the study, demographic, geographic, HIV and TB risk factor information will be collected on CPCRA patients with confirmed pulmonary or extrapulmonary TB. Mycobacterial culture results will be recorded. Retrospective data will be collected on CPCRA patients with confirmed tuberculosis who have been diagnosed since January 1992 until the time of site registration. Prospective data will be collected on CPCRA patients with confirmed tuberculosis diagnosed during the period of 1 to 2 years following site registration.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.1509 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Patients must meet the following criteria: CPCRA patients with confirmed pulmonary or extrapulmonary TB. Confirmed clinical TB requires a positive culture for Mycobacterium tuberculosis. NOTE: There is no requirement that patients have HIV infection.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 13 locations
Denver CPCRA / Denver Public Hlth
Denver, United StatesOpen Denver CPCRA / Denver Public Hlth in Google MapsVeterans Administration Med Ctr / Regional AIDS Program
Washington D.C., United StatesAIDS Research Alliance - Chicago
Chicago, United StatesLouisiana Comm AIDS Rsch Prog / Tulane Univ Med
New Orleans, United States